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Objective: Sleep is important for brain health. We analysed associations between usual sleep 
habits and MRI markers of neurodegeneration (brain atrophy), vascular damage (white matter 
hyperintensities, WMH) and waste clearance (perivascul r spaces, PVS) in older community-
dwelling adults. 
Method: We collected self-reported usual sleep duration, quality and medical histories from 
the Lothian Birth Cohort 1936 (LBC1936) age 76 years nd performed brain MRI. We 
calculated sleep efficiency, measured WMH and brain volumes, quantified PVS, and assessed 
associations between sleep measures and brain markers in multivariate models adjusted for 
demographic and medical history variables.   
Results: In 457 subjects (53% males, mean age 76±0.65 years), we found: brain and white 
matter loss with increased weekend daytime sleep (β=-0.114, P=0.03; β=-0.122, P=0.007 
respectively), white matter loss with less efficient sleep (β=0.132, P=0.011) and PVS 
increased with interrupted sleep (OR 1.84 95% CI, P=0.025).  
Conclusion:  Cross-sectional associations of sleep parameters with brain atrophy and more 
PVS suggest adverse relationships between usual sleep habits and brain health in older people 
that should be evaluated longitudinally.  
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Sleep is important for maintaining brain health. During sleep, the brain is thought to clear 
metabolic waste including proteins such as β-amyloid.(Shokri-Kojori, et al., 2018,Xie, et al., 
2013) Impaired sleep may increase the risk of adverse cognitive and health outcomes,(Gadie, 
et al., 2017,Spiegelhalder, et al., 2015) and is associated with slower processing speed in 
older subjects.(Cox, et al., 2019) Furthermore, sleep disorders such as obstructive sleep 
apnoea (OSA) are associated with increased risk of cerebrovascular disease,(Seiler, et al., 
2019,Sharma and Culebras, 2016) vascular lesions on magnetic resonance imaging (MRI) 
such as white matter hyperintensities (WMH),(Del Brutto, et al., 2017,Kim, et al., 2013,Song, 
et al., 2017) increased perivascular space (PVS) visibility,(Song, et al., 2017) and 
hippocampal atrophy.(Gadie, et al., 2017,Kim, et al., 2013,Owen, et al., 2018,Spiegelhalder, 
et al., 2015) 
 
Less is known about whether usual sleep habits in community-dwelling older people are 
associated with neuroimaging changes. In cognitively normal, late middle-aged and older 
adults, short sleep duration was associated cross-sectionally with worse cortical and 
hippocampus atrophy,(Carvalho, et al., 2017,Sexton, et al., 2014,Spira, et al., 2016) and 
longitudinally, with more brain atrophy and cognitive decline.(Lo, et al., 2014,Sexton, et al., 
2014,Sexton, et al., 2017) Poor sleep quality was associated with reduced white matter 
structural integrity on MRI in 448 community-dwelling subjects aged 60-82 years,(Sexton, et 
al., 2017)  and with WMH (but not microbleeds or lacunes) in 311 older community-dwelling 
people.(Del Brutto, et al., 2015) However, in another community-based study (n=970), 
neither sleep quality nor duration were related to any small vessel disease (SVD) 















background vascular risk, since all SVD lesions and brain atrophy worsen with advancing age 
and vascular risk factor exposure. 
 
Despite interest in PVS and their role during sleep in rodents,(Iliff, et al., 2015) few studies 
have assessed usual sleep habits and PVS, or other vascular and neurodegenerative disease 
markers, in humans.(Song, et al., 2017) PVS are visible on T2- and T1-weighted brain MRI 
and are associated with other features of SVD, hypertension, cognitive impairment and 
dementia.(Debette, et al., 2018,Francis, et al., 2019,Passiak, et al., 2019) Two studies in 
patients with cerebrovascular disease and community-dwelling subjects (n=26 and n=97 
respectively) found sleep abnormalities including sleep efficiency on polysomnography were 
associated with increased PVS visibility,(Berezuk, et al., 2015,Del Brutto, et al., 2019) and in 
a wider sample of 388 community-dwelling subjects including the 97 above, a univariate 
association between poor sleep quality and increased visible basal ganglia PVS was 
attenuated after co-variate adjustment.(Del Brutto, e  al., 2019) 
 
Based on self-reported sleep habits, we found previously that increased daytime sleep 
duration was associated with slower processing speed cross-sectionally, and with decline in 
visuospatial processing between ages 70 and 76 in community-dwelling subjects.(Cox, et al., 
2019) In the current analysis, we assessed the sameco munity-dwelling subjects at age 76 
for associations between self-reported sleep habits and vascular (PVS, WMH) or 


















Study participants were members of the Lothian Birth Cohort 1936 (LBC1936) who are 
community-dwelling older adults, all born in 1936, and living in South-East Scotland when 
recruited between 2004 and 2007.(Deary, et al., 2012) The LBC1936 underwent medical and 
cognitive assessments at mean ages 70 (n=1091, Wave1), 73 (n=700, Wave 2), and 76 years 
(n=488, Wave 3),(Deary, et al., 2012,Deary, et al., 2007)  brain MRI(Wardlaw, et al., 2011) 
at waves 2 and 3, and  completed a short Sleep Questionnaire at wave 3. We used concurrent 
medical, MRI and sleep data from Wave 3 in the present analysis.  
 
2.2 Regulatory 
Written informed consent was obtained from all participants under protocols approved by the 
Lothian (REC 07/MRE00/58) and Scottish Multicentre (MREC/01/0/56) Research Ethics 
Committees. Participants provided demographic information and medical history including of 
cardiovascular disease, diabetes, hypertension, smoking (never, previously or current), 
hypercholesterolemia and stroke.(Deary, et al., 2007,Wardlaw, et al., 2014) We excluded 
participants with a diagnosis of dementia. 
 
2.3 Sleep Variables 
We used a short Sleep Questionnaire adapted from the Pittsburgh Sleep Quality 
Index.(Buysse, et al., 1989) As described previously,(Cox, et al., 2019) participants recorded  
their sleep quality in the last month (very bad=0, fairly bad=1, fairly good=2, very good =3). 
Based on Patient-Partner Questionnaire used in the Sle p Medicine Unit, Royal Infirmary 
Edinburgh (author RLR) participants also provided estimates of their typical time spent in 
bed and sleep duration for night-time and daytime on weekdays and weekends, sleep latency 
(time taken to fall asleep), and whether their night-time sleep was regularly interrupted 















hours for uniformity and calculated hours slept during the night (night-time), during the day 
(daytime), on weekdays and weekends. We calculated ‘sleep efficiency’ using the sleep 
timings as reported in the Patient-Partner questionnaire above and the principles described in 
(Berezuk, et al., 2015) as: 
[Number of night-time hours slept ÷ total number of night-time hours spent in bed] x 100  
 
2.4 Brain Magnetic Resonance Imaging and Feature Analysis 
Whole brain MRI was performed on a 1.5T GE Signa Horizon HDx scanner (General 
Electric, Milwaukee, WI, USA) using a self-shielding gradient set with a maximum gradient 
strength of 33 mT/m, and an 8-channel phased-array he d coil. The imaging data included: 
T1-, T2-, T2*- and Fluid Attenuated Inversion Recovery (FLAIR)-weighted whole brain scans, 
all details described previously.(Wardlaw, et al., 2011).  
 
All analyses were blind to sleep, medical, cognitive and all other parameters. We measured 
intracranial volume (ICV), total brain volume (TBV), WMH volumes, normal-appearing 
white matter (NAWM) and grey matter (GM) volumes, using a validated semi-automatic 
image analysis method.(Valdés Hernández, et al., 2015) We measured intracranial volume 
(ICV) using the Object Extraction Tool in the Analyze 9.0TM,(Wardlaw, et al., 2011) and 
expressed all brain and WMH volumes as the proportion of ICV (% ICV), indicating tissue 
loss from peak adulthood.(Royle, et al., 2013,Wardlaw, et al., 2011) 
 
We assessed PVS in the basal ganglia (BG) and centrum semiovale (CS) on a validated four-
point scale (where 0=none and 4=40 and above PVS per sid ),(Potter, et al., 2015) defined as 
previously.(Wardlaw, et al., 2013) The intra- and iter-rater kappa statistics for PVS rating 

















2.5 Statistical analyses 
We performed all statistical analyses using SPSS version 19 (IBM Inc. New York, USA), 
with all statistical tests being two-tailed, P values <0.05 considered statistically significant 
and a more rigorous value of P<0.001 to minimise spurious findings due to multiple 
comparisons. Sleep duration and measures of atrophy were normally distributed; sleep quality 
and interruption were categorical; sleep efficiency was left-skewed but could not be 
normalised by any standard transformation and therefore was not transformed. We log 
transformed WMH as it was very right-skewed. We compared gender, sleep efficiency and 
sleep duration using independent t-tests, and sleep quality and interruption using Mann-
Whitney U test. We did not perform a power calculation since the sample was limited by the 
available cohort, but we were careful not to include too many co-variates, check the fit of 
models and set rigorous P values. 
 
First, we examined consistencies amongst the sleep variables using bivariate analysis and 
Cronbach’s alpha. Next, we examined associations between sleep variables and medical 
history (bivariate analysis) and lastly, we used multivariate linear regression models to 
examine associations between sleep variables and imaging parameters (PVS, % WMH in 
ICV and measures of atrophy) adjusted for medical and demographic variables. We ran 
models using each sleep variable as the dependent (outcome) variable and each brain volume, 
% WMH in ICV and PVS as the independent variable. Four models were developed in a step-
wise manner, beginning with the dependent variable, independent variable, age and sex, then 
adding medical variables (diabetes, smoking, body mass index, cholesterol and blood 















problems) and finally adding arthritis. Final covariates were sex, age in days at scanning, and 
self-reported history of cardiovascular disease, diabetes, hypertension, smoking, 
hypercholesterolemia and stroke. Similarly, we used r gression to test the association 
between sleep efficiency and the predictor variables, correcting for all covariates. The 
residuals of the regression model were normally distributed, suggesting a good fit of the 
model. We assessed sleep quality and interruption (yes/no), PVS and atrophy using 
multinomial regression analysis with the sleep variable as the outcome and PVS, WMH and 
measures of atrophy as the predictor variables (reference category for quality outcome 
variable = ‘very bad’), controlled for all covariates.  
 
3.0 Results 
3.1 Subjects: Of the 488 subjects who underwent brain MRI, 457 had complete sleep, brain 
MRI and clinical data, of whom 53% were male (Table 1). The mean age at MRI scanning 
was 76.31±0.65 years (minimum 74.73, maximum 77.75 years). Almost half of the 
participants had hypertension, hypercholesterolemia or rthritis, were current or ex-smokers, 
12% had diabetes, 33% had heart disease and 11% had previous stroke.  The mean ±SD 
WMH volume was 16±15ml, mean 1.1±1.0% of the ICV. The median (IQR) basal ganglia 
PVS score was 1.0 (0) and centrum semiovale score was 2.0 (1.0).  The TBV, NAWM, and 
GM occupied a mean±SD proportion of the ICV of 68±2%, 32±2%, and 32±2% respectively. 
Males generally slept longer than females (Table 1). 
 
3.2 Sleep measures, inter-relationships:  
The sleep variables were internally consistent. Weekend and weekday sleep durations were 
highly correlated (eg at nightime Pearson r=0.970, P<0.001, Supplementary Table S1, 















seen for weekends (Supplementary Table S1): those who slept less during the night slept 
more during the day (r=-0.20, P<0.001) and had poorer sleep efficiency (r=-0.11, P=0.007). 
Night-time sleep duration correlated positively with sleep quality (r=0.57, P<0.001) and 
efficiency (r=0.501, P<0.001). Sleep efficiency correlated positively with sleep quality 
(r=0.486, P<0.001).  Interrupted sleep was present in about 20% of the population and 
associated inversely with sleep efficiency (r=-0.12, P=0.003) and quality (r=-0.25, P<0.001).  
 
3.3 Sleep, demographic and medical variables:  
There were no associations between self-reported slep variables and age, BMI, smoking 
habit or medical histories in adjusted models, apart from diabetes (r=-0.10, P=0.012) and 
arthritis (r=-0.17, P<0.001) both of which were associated with shorter night-time sleep 
(Supplementary Table S2).  
 
3.4 Sleep and imaging variables:  
Increased weekend daytime sleep duration was associted with reduced total brain and 
NAMW volumes (β=-0.11, P=0.03; and β=-0.12, P=0.01 respectively; Table 1, Figure 1). 
Lower sleep efficiency was associated with reduced NAWM volume (β=0.13, P=0.011, Table 
2, Figure 2). There was no association between night-time sleep duration or sleep quality and 
brain volume losses, although the directions of effects were consistent.  
 
Interrupted sleep was associated with more visible basal ganglia PVS (OR 1.84, 95% CI 
1.08-3.15), but not WMH or brain volumes (Table 2). 

















We show that adverse usual sleeping habits, specifically increased day-time sleep and lower 
sleep efficiency, are associated with signs of neurodegeneration and cerebral microvascular 
dysfunction, when measured contemporaneously in a large sample of community-dwelling 
people aged around 76. Reduced white matter provides a mechanistic substrate for the 
association between increased daytime sleep and slower processing speed found previously in 
this cohort.(Cox, et al., 2019) The association betwe n interrupted sleep and increased PVS 
visibility suggests that sleep disturbance might affect brain waste clearance, or vice versa. 
The lack of association in this study between usual leep habits and WMH may be due to the 
co-association between age and WMH reflected in wider age-ranges in prior studies. This is, 
to the best of our knowledge, the largest and only study to assess contemporaneous 
associations between sleep duration, quality, effici ncy, interruption and MRI markers of 
cerebrovascular and neurodegenerative disease at older ages. These cross-sectional 
associations require testing in longitudinal studies to determine whether alterations in usual 
sleep habits lead to development of vascular and neurod generative lesions, or vice versa, in 
older age.(Gadie, et al., 2017,Scullin, 2017)  
 
Brain atrophy is associated with cognitive decline, d mentia and early death (Cole, et al., 
2018) and impaired sleep may increase the risk of adverse cognitive and health 
outcomes.(Gadie, et al., 2017,Spiegelhalder, et al., 2015) The independent association of 
reduced white matter (and total brain) volume with adverse sleep parameters of increased 
weekend daytime sleep and poorer sleep efficiency is novel since previous studies reported 
on cortical or hippocampal volume loss but not white matter loss.(Carvalho, et al., 2017,Lo, 
et al., 2014,Sexton, et al., 2014,Spira, et al., 2016) Reasons for the absence of association of 
brain volume loss with night-time or weekday daytime sleep in our study are unclear 















retirement age but nonetheless may have had weekday commitments and more time to rest 
during the day at weekends. The finding is consistent with the Honolulu-Asian Ageing Study 
(n=167) which found that reduced slow wave sleep identified with polysomnography was 
associated with brain atrophy at post-mortem on average 10 years later.(Gelber, et al., 2015)  
 
The association of increased PVS with interrupted sl ep is also notable. PVS are pathways 
for clearing interstitial fluid and metabolic waste which is thought to increase during sleep, at 
least in rodents.(Iliff, et al., 2015) Increased PVS on MRI associate with SVD, hypertension, 
cognitive decline and dementia.(Debette, et al., 2018,Francis, et al., 2019,Passiak, et al., 
2019)  Increased PVS visibility was associated cross-sectionally with abnormal sleep 
efficiency in two studies on polysomnography,(Berezuk, et al., 2015,Del Brutto, et al., 2019) 
but an association with sleep quality did not survive co-variate adjustment in a larger sample 
of community-dwelling subjects.(Del Brutto, et al., 2019) Sleep efficiency reflects some 
elements of interrupted sleep that we found to be associated with increased basal ganglia PVS 
in co-variate-adjusted analysis in the present study. These findings require confirmation in 
larger studies in other populations and in longitudinal analysis. Data on PVS function in 
humans, including in wakefulness versus sleep, is very limited.(Ringstad, et al., 2017) If 
sleep is important for PVS fluid clearance in humans, then enlargement of the PVS in 
subjects with interrupted sleep might indicate fluid stagnation and waste deposition in PVS, 
consistent with increased β-amyloid seen in brain and CSF with short-term sleep disruption in 
volunteers.(Ju, et al., 2017,Shokri-Kojori, et al., 2018,Varga, et al., 2016)  However, the 
present cross-sectional study does not determine the direction of association and it is possible 
that sleep interruption might reflect adverse effects of dilated PVS on sleep control centres in 
the hypothalamus. These findings will be examined in longitudinal studies to determine the 
















We did not find associations between WMH, a common marker of vascular disease and 
dementia,(Debette, et al., 2018,Georgakis, et al., 2019) and sleep variables, but the study may 
have been underpowered to detect a small association. However, with 457 subjects, this is the 
largest study of usual sleep habits and brain changes to date. Our findings concur with one 
other community-based sample with a wide age range(Zuurbier, et al., 2015) but not with  
several other studies which included populations with more vascular disease or pathological 
sleep, e.g. 237 persons of poor cardiovascular health mean age 70 where poor sleep quality 
was associated with WMH,(Del Brutto, et al., 2015) 170 subjects with clinically-defined 
OSA in whom the severity of sleep apnoea was independently associated with WMH(Song, 
et al., 2017) and 104 persons in whom OSA was associated with WMH.(Del Brutto, et al., 
2017,Ramirez, et al., 2015,Sharma and Culebras, 2016) The absence of an association 
between sleep measures and WMH in the LBC1936 may reflect that WMH may be 
associated with OSA specifically (rather than usual leep habits), that LBC1936 subjects have 
better average cardiovascular health than populations attending sleep clinics, the wider age 
range of subjects in other studies increasing the risk of confounding WMH associations by 
age, or the lower sensitivity of self-reported sleep variables versus polysomnography. 
However, the sleep questionnaire detected small differences in sleep variables between men 
and women, in those with diabetes or arthritis in the current analysis, and with subtle changes 
in cognitive function in prior analysis,(Cox, et al., 2019) suggesting that it is sensitive to 
modest associations with other variables. We suggest that further analyses of associations 
between sleep variables and WMH are required in populations with high or low 
cardiovascular risk profiles and/or pathological sleep complaints to determine if the 
association of sleep parameters and WMH is skewed by patient characteristics or increases in 
















The study strengths include the large sample, narrow age range minimising the confounding 
effect of age, and use of extensively validated imaging measurements. The study limitations 
included use of a self-report questionnaire rather an polysomnography or other recording 
device. This may have reduced our sensitivity for detecting modest associations between 
sleep timings, including the derived variables such as sleep efficiency, and brain changes. 
However, devices may not be completely reliable, our sleep measures were internally 
consistent and identified small but significant differences for some characteristics including 
cognition.(Cox, et al., 2019) Longer night-time sleep duration, better sleep quality and sleep 
efficiency were all positively correlated; reduced night-time sleep was associated with  more 
daytime sleep, interrupted sleep and lower sleep quality. These consistent associations 
support the reliability and validity of self-reported sleep data.(Buysse, et al., 1989,Cox, et al., 
2019) The association of diabetes and arthritis with shorter night-time sleep duration is 
unsurprising since diabetes may increase nocturia and arthritis causes discomfort. As noted 
above, the study may have been underpowered to detect some subtle associations, although to 
the best of our knowledge it is the largest study to date to assess sleep variables and age-
associated brain lesions. We did not perform a power calculation since the sample was 
limited by the available cohort. Computational methods to assess PVS are now 
emerging(Ballerini, et al., 2018) which can quantify not only PVS count and total volume but 
also individual PVS length, width, size, sphericity, location and orientation and these may 
prove to be far more sensitive in future analysis to subtle associations between early PVS 
pathology and sleep habits. We did not assess, or cont ol for, the influence that respiratory 
function, body mass index, use of medications, mood or presence/absence of a partner might 















sleep, corrected for common vascular risk factors and diseases that are known to affect SVD 
features.(Debette, et al., 2018,Georgakis, et al., 2019)   
 
Sleep is important for brain health. One night of sleep deprivation,(Shokri-Kojori, et al., 
2018) deliberately interrupted slow-wave sleep,(Ju, et al., 2017) and reduced slow-wave 
sleep(Varga, et al., 2016) are associated with increased Β-amyloid in the brain(Shokri-Kojori, 
et al., 2018) or CSF(Ju, et al., 2017,Varga, et al., 2016) of healthy volunteers. The association 
of reduced sleep duration, quality, efficiency and i creased sleep interruption with brain 
atrophy and increased PVS provides structural correlates whereby sleep impairment might 
affect brain health.  Future research should address long-term associations of sleep 
parameters with neuroimaging markers of neurodegeneration and vascular disease, and with 
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Figure 1:  Scatter plot with regression line showing associations between (a) Daytime sleep 
duration at weekends and % TBV in ICV and (b) Daytime sleep duration at weekends and % 
NAWM in ICV.   Note, Beta (p values) account for all covariates in the models, including 
age, sex, diabetes, smoking, BMI, cholesterol, high blood pressure, stroke, cardiovascular 
disease, peripheral vascular disease and arthritis. TBV = Total Brain Volume. ICV = 
Intracranial Volume. NAWM = Normal Appearing White Matter.  
 
Figure 2: Scatter plot with regression line showing associations between  (a) Sleep efficiency 
and % NAWM in ICV and (b) Sleep efficiency and % WMH in ICV.  Note, Beta (p values) 
account for all covariates in the models, including a e, sex, diabetes, smoking, BMI, 
cholesterol, high blood pressure, stroke, cardiovascul r disease, peripheral vascular disease 
and arthritis. TBV = Total Brain Volume. ICV = Intracranial Volume. NAWM = Normal 


























Table 1: Demographic, health, sleep and imaging parameters for the study population 
 N=457 Measures   Mean (SD) 
 Demographic  Age in years,  mean (SD)   76.31(0.65) 
  % men   53  
    YES NO 
Health conditions Hypertension (%) 55 45 
  Diabetes (%) 12 88 
  Prior stroke (%) 11 89 
  Smoking (%) current or ever smoked 49 51 
  Hypercholesterolemia (%) 47 53 
  Cardiovascular (Heart) disease (%) 33 67 
  Peripheral vascular disease (%) 21 79 
  Arthritis (%) 47 53 
Sleep Variables Measures of sleep Mean (SD) 
  Night-time sleep 
duration (hours) 
Weekdays M: 6.92 (1.25), F: 6.73 (1.34) 
  Weekends M: 7.00 (1.29), F: 6.79(1.36)* 
  Day-time Sleep 
duration (hours) 
Weekdays M: 1.21 (1.61), F: 0.85(1.2)** 
  Weekends M: 1.19 (1.68), F: 0.79(1.19)** 
  Sleep efficiency weekdays (%) M: 94.27(5.88), F: 91.73(7.85) ** 
  Sleep efficiency weekends (%) M: 95.49(5.60), F: 91.65(8.31) ** 
  Sleep Quality, Median and IQR,  2 (1), of 4 categories 
  Interrupted sleep NO = 82% YES = 18% 
Brain Imaging 
findings PVS BG, Median (IQR) 1 (0) 
  PVS CS, Median (IQR) 2 (1.00) 
    Mean (SD) % in ICV, Mean (SD) 
  ICV (ml) 1439.04(1367) 
  TBV (ml) 975.73(90.69) 68 (21) 
  WMH (ml) 15.86(14.64) 11 (10) 
  NAWM (ml) 464.59(53.21) 32 (20) 
  GM (ml) 465.79(43.31) 32 (20) 
Note.  BG = Basal Ganglia, CS = Centrum Semiovale, PVS = Perivascular Spaces, WMH = White 
Matter Hyperintensity, NAWM = Normal Appearing White Matter. GM = Grey Matter. TBV = Total 
Brain Volume. ICV = Intracranial Volume, CVD = cardiovascular disease, M= Male, F=Female, * 
Male significantly different from female at P<0.01. ** Male significantly different from female at 
















Table 2: Linear regression models (A, C) and multinomial regression models (B), all fully 
adjusted, for the association between sleep duration, interrupted sleep, sleep efficiency and  
brain parameters.  
A 
Night-time sleep 







 Standardized β (P value) 
PVS BG 0.078 (0.092) 0.077 (0.099) -0.035( 0.461) -0.031( 0.517) 
%WMH 0.000 (0.980) 0.000 (0.970) 0.05 (0.28) 0.06 (.25) 
% TBV -0.038 (0.453) -0.051 (0.321) -0.075(0.151) -0.11(0.030) 
% 
NAWM -0.031 (0.524) -0.036 (0.465) -0.09(0.07) -0.12(0.014) 
  
 B Interrupted Sleep   
  OR (95% CI) SE P value   
PVS BG 1.84 (1.08,3.15) 0.273 0.025   
%WMH 6.13 (0.00,999.99) 13.153 0.89   
%TBV 99.9 (0.04,99.99) 6.722 0.139   
%NAWM 0.69 (0.00,999.99) 6.736 0.956   
 C Sleep Efficiency  
 Standardized β (P value) 
PVS BG -0.029 (0.562)       
%WMH -0.056 (0.274)       
%TBV 0.067 (0.217)       
%NAWM 0.13 (0.011)       
Note. Sleep variables were the dependent variables while brain parameters were the independent 
variables. Distinct models were run for each sleep variable and brain parameter.  These final fully 
adjusted models accounted for age, sex, diabetes, smoking, BMI, Cholesterol, high blood pressure, 
stroke, cardiovascular disease, peripheral vascular disease, other circulatory problems and arthritis. 
PVS BG = Perivascular spaces in the Basal Ganglia; WMH = White matter hyperintensities; 







































• Adverse usual sleep habits associate with key brain changes in older people.  
• White matter loss may explain association of daytime sleep and processing speed.  
• PVS increase with interrupted sleep may indicate impaired brain waste clearance.  
• These findings may explain why usual sleep is important for older brain health.  
 
